| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1181-1191, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
BM Kraling, MJ Razon, LM Boon, D Zurakowski, C Seachord, RP Darveau, JB Mulliken, CL Corless and J Bischoff
Surgical Research Laboratory, Children's Hospital, Boston, Massachusetts 02115, USA.
E-selectin, an endothelial-cell-specific leukocyte adhesion molecule, may also function in angiogenesis. To investigate its role in a noninflammatory angiogenic disease, E-selectin was analyzed by immunohistochemistry in specimens of proliferative phase and involutive phase hemangiomas. Hemangioma is an endothelial cell tumor of capillary blood vessels that grows rapidly during infancy and regresses spontaneously during childhood. E-selectin expression was high in proliferative phase specimens and was co-localized with dividing microvascular endothelial cells. Relative to the number of blood vessels, E-selectin declined significantly in involutive phase specimens demonstrating that E-selectin correlates with angiogenesis in the tumors. E-selectin was not detected in quiescent endothelium but was co-localized in dividing microvascular endothelial cells in placenta and neonatal foreskin, two tissues with ongoing growth of microvessels. These in vivo studies support the hypothesis that E- selectin functions in angiogenesis and suggest that E-selectin may be a marker for proliferating endothelium.
This article has been cited by other articles:
 |
|
 |
|
  M. J. Sundine and G. A. Wirth Hemangiomas: An Overview Clinical Pediatrics, April 1, 2007; 46(3): 206 - 221. [PDF]
|
|
|
|
 |
|
 Y. Nishiwaki, M. Yoshida, H. Iwaguro, H. Masuda, N. Nitta, T. Asahara, and M. Isobe Endothelial E-Selectin Potentiates Neovascularization via Endothelial Progenitor Cell-Dependent and -Independent Mechanisms Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Khan, J. M. Melero-Martin, X. Wu, S. Paruchuri, E. Boscolo, J. B. Mulliken, and J. Bischoff Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin Blood, August 1, 2006; 108(3): 915 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, J. Fuhr, E. Boye, S. Gyorffy, S. Soker, A. Atala, J. B. Mulliken, and J. Bischoff Mesenchymal Stem Cells and Adipogenesis in Hemangioma Involution Stem Cells, June 1, 2006; 24(6): 1605 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Smolinski and A. C. Yan Hemangiomas of Infancy: Clinical and Biological Characteristics Clinical Pediatrics, November 1, 2005; 44(9): 747 - 766. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Wu, E. Rabkin-Aikawa, K. J. Guleserian, T. E. Perry, Y. Masuda, F. W. H. Sutherland, F. J. Schoen, J. E. Mayer Jr., and J. Bischoff Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H480 - H487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, K. S. Moulton, M. K. Khan, S. Vineberg, E. Boye, V. M. Davis, P. E. O'Donnell, J. Bischoff, and D. S. Milstone E-selectin is required for the antiangiogenic activity of endostatin PNAS, May 25, 2004; 101(21): 8005 - 8010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Phillips, K. G. Barringhaus, J. M. Sanders, S. E. Hesselbacher, A. C. Czarnik, D. Manka, D. Vestweber, K. Ley, and I. J. Sarembock Single Injection of P-Selectin or P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Blocks Neointima Formation After Arterial Injury in Apolipoprotein E-Deficient Mice Circulation, May 6, 2003; 107(17): 2244 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tei, N. Kawakami-Kimura, O. Taguchi, K. Kumamoto, S. Higashiyama, N. Taniguchi, K.'i. Toda, R. Kawata, Y. Hisa, and R. Kannagi Roles of Cell Adhesion Molecules in Tumor Angiogenesis Induced by Cotransplantation of Cancer and Endothelial Cells to Nude Rats Cancer Res., November 1, 2002; 62(21): 6289 - 6296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Ritter, M. I. Dorrell, J. Edmonds, S. F. Friedlander, and M. Friedlander From the Cover: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis PNAS, May 28, 2002; 99(11): 7455 - 7460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu, J. Varughese, L. F. Brown, J. B. Mulliken, and J. Bischoff Increased Tie2 Expression, Enhanced Response to Angiopoietin-1, and Dysregulated Angiopoietin-2 Expression in Hemangioma-Derived Endothelial Cells Am. J. Pathol., December 1, 2001; 159(6): 2271 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Moghimi, A. C. Hunter, and J. C. Murray Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Manka, R. G. Collins, K. Ley, A. L. Beaudet, and I. J. Sarembock Absence of P-Selectin, but Not Intercellular Adhesion Molecule-1, Attenuates Neointimal Growth After Arterial Injury in Apolipoprotein E-Deficient Mice Circulation, February 20, 2001; 103(7): 1000 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Chervenak and N. P. Illsley Episialin Acts as an Antiadhesive Factor in an In Vitro Model of Human Endometrial-Blastocyst Attachment Biol Reprod, July 1, 2000; 63(1): 294 - 300. [Abstract] [Full Text]
|
|
|
|
|
|
A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kruse, R. Hallmann, and E. C. Butcher Specialized Patterns of Vascular Differentiation Antigens in the Pregnant Mouse Uterus and the Placenta Biol Reprod, December 1, 1999; 61(6): 1393 - 1401. [Abstract] [Full Text]
|
|
|
|
|
|
R. R. Langley, J. Russell, M. J. Eppihimer, S. J. Alexander, M. Gerritsen, R. D. Specian, and D. N. Granger Quantification of murine endothelial cell adhesion molecules in solid tumors Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1156 - H1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Luo, G. Paranya, and J. Bischoff Noninflammatory Expression of E-Selectin Is Regulated by Cell Growth Blood, June 1, 1999; 93(11): 3785 - 3791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Blei, J. Walter, S. J. Orlow, and D. A. Marchuk Familial Segregation of Hemangiomas and Vascular Malformations as an Autosomal Dominant Trait Arch Dermatol, June 1, 1998; 134(6): 718 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Eichenfield Evolving Knowledge of Hemangiomas and Vascular Malformations: Beyond Strawberries and Port Wine Arch Dermatol, June 1, 1998; 134(6): 740 - 742. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Litwin, K. Clark, L. Noack, J. Furze, M. Berndt, S. Albelda, M. Vadas, and J. Gamble Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31) J. Cell Biol., October 6, 1997; 139(1): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Boudreau, C. Andrews, A. Srebrow, A. Ravanpay, and D. A. Cheresh Induction of the Angiogenic Phenotype by Hox D3 J. Cell Biol., October 6, 1997; 139(1): 257 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Spragg, D. R. Alford, R. Greferath, C. E. Larsen, K.-D. Lee, G. C. Gurtner, M. I. Cybulsky, P. F. Tosi, C. Nicolau, and M. A. Gimbrone Jr. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system PNAS, August 5, 1997; 94(16): 8795 - 8800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Garlanda and E. Dejana Heterogeneity of Endothelial Cells : Specific Markers Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1193 - 1202. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
